| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1352458512436592 |
| P698 | PubMed publication ID | 22492132 |
| P50 | author | Carolyn A. Young | Q37374325 |
| P2093 | author name string | A Tennant | |
| J Woolmore | |||
| C P Hawkins | |||
| R J Mills | |||
| P2860 | cites work | Temporal trends in the incidence of multiple sclerosis: a systematic review | Q22241655 |
| Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis | Q22252943 | ||
| Self-efficacy: toward a unifying theory of behavioral change | Q28267991 | ||
| Disease severity and domain-specific arthritis self-efficacy: relationships to pain and functioning in patients with rheumatoid arthritis | Q33910523 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis | Q34561309 | ||
| Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distress | Q36848954 | ||
| The development, assessment, and selection of questionnaires | Q36911008 | ||
| The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? | Q37020343 | ||
| Self-efficacy and environmental correlates of physical activity among older women and women with multiple sclerosis | Q37323295 | ||
| Understanding physical activity in adults with type 2 diabetes after completing an exercise intervention trial: A mediation model of self-efficacy and autonomous motivation | Q38551092 | ||
| Self-efficacy, depression, and physical distress in males and females with cancer | Q39280058 | ||
| Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? | Q39749797 | ||
| Specifying the determinants of the initiation and maintenance of behavior change: an examination of self-efficacy, satisfaction, and smoking cessation | Q40282976 | ||
| Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject | Q46402093 | ||
| Development of a scale to measure core beliefs and perceived self efficacy in adults with epilepsy | Q48797337 | ||
| Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. | Q52193535 | ||
| Role of self-efficacy in predicting outcomes from a programme for controlled drinking. | Q52423273 | ||
| Application of Rasch analysis in the development and application of quality of life instruments. | Q52858735 | ||
| Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale. | Q53395149 | ||
| Self-care self-efficacy, quality of life, and depression after stroke. | Q53524087 | ||
| Prediction of psychological adjustment to multiple sclerosis. | Q53592502 | ||
| Two New Properties of Mathematical Likelihood | Q56657059 | ||
| Bridging the intention–behaviour gap: Planning, self-efficacy, and action control in the adoption and maintenance of physical exercise | Q57603165 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1326-1333 | |
| P577 | publication date | 2012-04-05 | |
| P1433 | published in | Multiple Sclerosis Journal | Q1952449 |
| P1476 | title | The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome | |
| P478 | volume | 18 |
| Q37575546 | A Randomised Controlled Trial of Efficacy of Cognitive Rehabilitation in Multiple Sclerosis: A Cognitive, Behavioural, and MRI Study. |
| Q39501540 | Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life |
| Q92069108 | Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives |
| Q46843483 | Disease-specific self-efficacy in the eosinophilic gastrointestinal disorders |
| Q50594825 | Further validation of the Multiple Sclerosis Self-Efficacy Scale. |
| Q92756449 | German translation, cultural adaption and validation of the unidimensional self-efficacy scale for multiple sclerosis: a study protocol |
| Q38069035 | Methods and measures: what's new for MS? |
| Q35329502 | The Multiple Sclerosis-Fatigue Self- Efficacy (MS-FSE) scale: initial validation |
Search more.